Sonelokimab, CAS 1414386-05-2

Product Description: Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody comprised of monovalent camelid-derived nanobodies specific to human interleukin (IL)-17A, IL-17F, and human serum albumin VHHs. Sonelokimab has the potential for plaque-type psoriasis research[1][2].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Kim A Papp, et al. IL17A/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b study. Lancet. 2021 Apr 24;397(10284):1564-1575./[2]Martin A Rossotti, et al. Immunogenicity and humanization of single-domain antibodies. FEBS J. 2022 Jul;289(14):4304-4327.

CAS Number: 1414386-05-2

Molecular Weight: N/A

Compound Purity: 99.90

Research Area: Inflammation/Immunology

Solubility: H2O

Target: Interleukin Related

• SKU: MEXHY-P99397-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99397-1
• Green Labware: No
• Package Unit: 1 mg
• Quantity Unit: STK